Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise ...

Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...